These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Transcriptional Repressor BCL11A in Erythroid Cells. Zheng G; Orkin SH Adv Exp Med Biol; 2024; 1459():199-215. PubMed ID: 39017845 [TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9 Editing of the Sharma A; Boelens JJ; Cancio M; Hankins JS; Bhad P; Azizy M; Lewandowski A; Zhao X; Chitnis S; Peddinti R; Zheng Y; Kapoor N; Ciceri F; Maclachlan T; Yang Y; Liu Y; Yuan J; Naumann U; Yu VWC; Stevenson SC; De Vita S; LaBelle JL N Engl J Med; 2023 Aug; 389(9):820-832. PubMed ID: 37646679 [TBL] [Abstract][Full Text] [Related]
8. Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype. Weber L; Frati G; Felix T; Hardouin G; Casini A; Wollenschlaeger C; Meneghini V; Masson C; De Cian A; Chalumeau A; Mavilio F; Amendola M; Andre-Schmutz I; Cereseto A; El Nemer W; Concordet JP; Giovannangeli C; Cavazzana M; Miccio A Sci Adv; 2020 Feb; 6(7):. PubMed ID: 32917636 [TBL] [Abstract][Full Text] [Related]
9. Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding. Martyn GE; Wienert B; Yang L; Shah M; Norton LJ; Burdach J; Kurita R; Nakamura Y; Pearson RCM; Funnell APW; Quinlan KGR; Crossley M Nat Genet; 2018 Apr; 50(4):498-503. PubMed ID: 29610478 [TBL] [Abstract][Full Text] [Related]
10. Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression. Rajendiran V; Devaraju N; Haddad M; Ravi NS; Panigrahi L; Paul J; Gopalakrishnan C; Wyman S; Ariudainambi K; Mahalingam G; Periyasami Y; Prasad K; George A; Sukumaran D; Gopinathan S; Pai AA; Nakamura Y; Balasubramanian P; Ramalingam R; Thangavel S; Velayudhan SR; Corn JE; Mackay JP; Marepally S; Srivastava A; Crossley M; Mohankumar KM Mol Ther; 2024 Mar; 32(3):663-677. PubMed ID: 38273654 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin. Ravi NS; Wienert B; Wyman SK; Bell HW; George A; Mahalingam G; Vu JT; Prasad K; Bandlamudi BP; Devaraju N; Rajendiran V; Syedbasha N; Pai AA; Nakamura Y; Kurita R; Narayanasamy M; Balasubramanian P; Thangavel S; Marepally S; Velayudhan SR; Srivastava A; DeWitt MA; Crossley M; Corn JE; Mohankumar KM Elife; 2022 Feb; 11():. PubMed ID: 35147495 [TBL] [Abstract][Full Text] [Related]
12. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698 [TBL] [Abstract][Full Text] [Related]
13. Dual function NFI factors control fetal hemoglobin silencing in adult erythroid cells. Qin K; Huang P; Feng R; Keller CA; Peslak SA; Khandros E; Saari MS; Lan X; Mayuranathan T; Doerfler PA; Abdulmalik O; Giardine B; Chou ST; Shi J; Hardison RC; Weiss MJ; Blobel GA Nat Genet; 2022 Jun; 54(6):874-884. PubMed ID: 35618846 [TBL] [Abstract][Full Text] [Related]
14. Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs. Han W; Qiu HY; Sun S; Fu ZC; Wang GQ; Qian X; Wang L; Zhai X; Wei J; Wang Y; Guo YL; Cao GH; Ji RJ; Zhang YZ; Ma H; Wang H; Zhao M; Wu J; Bi L; Chen QB; Li Z; Yu L; Mou X; Yin H; Yang L; Chen J; Yang B; Zhang Y Cell Stem Cell; 2023 Dec; 30(12):1624-1639.e8. PubMed ID: 37989316 [TBL] [Abstract][Full Text] [Related]
15. Potent and uniform fetal hemoglobin induction via base editing. Mayuranathan T; Newby GA; Feng R; Yao Y; Mayberry KD; Lazzarotto CR; Li Y; Levine RM; Nimmagadda N; Dempsey E; Kang G; Porter SN; Doerfler PA; Zhang J; Jang Y; Chen J; Bell HW; Crossley M; Bhoopalan SV; Sharma A; Tisdale JF; Pruett-Miller SM; Cheng Y; Tsai SQ; Liu DR; Weiss MJ; Yen JS Nat Genet; 2023 Jul; 55(7):1210-1220. PubMed ID: 37400614 [TBL] [Abstract][Full Text] [Related]
16. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Xu J; Peng C; Sankaran VG; Shao Z; Esrick EB; Chong BG; Ippolito GC; Fujiwara Y; Ebert BL; Tucker PW; Orkin SH Science; 2011 Nov; 334(6058):993-6. PubMed ID: 21998251 [TBL] [Abstract][Full Text] [Related]
17. A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction. Perumbeti A; Higashimoto T; Urbinati F; Franco R; Meiselman HJ; Witte D; Malik P Blood; 2009 Aug; 114(6):1174-85. PubMed ID: 19474450 [TBL] [Abstract][Full Text] [Related]
18. Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin. Pestina TI; Hargrove PW; Jay D; Gray JT; Boyd KM; Persons DA Mol Ther; 2009 Feb; 17(2):245-52. PubMed ID: 19050697 [TBL] [Abstract][Full Text] [Related]
19. Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes. Campbell AD; Cui S; Shi L; Urbonya R; Mathias A; Bradley K; Bonsu KO; Douglas RR; Halford B; Schmidt L; Harro D; Giacherio D; Tanimoto K; Tanabe O; Engel JD Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18808-13. PubMed ID: 22042865 [TBL] [Abstract][Full Text] [Related]
20. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease. Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]